An ACE therapy for COVID-19
Christopher B. Rodell
Abstract
Recombinant human soluble ACE2 inhibits SARS-CoV-2 viral infection in human organoids in vitro.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineVirologyPharmacologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesTryptophan and brain disorders